Search Results - "Dow, Geoffrey S."

Refine Results
  1. 1

    Synthesis and biological evaluation of the first pentafluorosulfanyl analogs of mefloquine by Wipf, Peter, Mo, Tingting, Geib, Steven J, Caridha, Diana, Dow, Geoffrey S, Gerena, Lucia, Roncal, Norma, Milner, Erin E

    Published in Organic & biomolecular chemistry (01-01-2009)
    “…Two novel SF5 analogs of the antimalarial agent mefloquine were synthesized in 5 steps and 10-23% overall yields and found to have improved activity and…”
    Get more information
    Journal Article
  2. 2

    Radical curative efficacy of tafenoquine combination regimens in Plasmodium cynomolgi-infected Rhesus monkeys (Macaca mulatta) by Dow, Geoffrey S, Gettayacamin, Montip, Hansukjariya, Pranee, Imerbsin, Rawiwan, Komcharoen, Srawuth, Sattabongkot, Jetsumon, Kyle, Dennis, Milhous, Wilbur, Cozens, Simon, Kenworthy, David, Miller, Anne, Veazey, Jim, Ohrt, Colin

    Published in Malaria journal (29-07-2011)
    “…Tafenoquine is an 8-aminoquinoline being developed for radical cure (blood and liver stage elimination) of Plasmodium vivax. During monotherapy treatment, the…”
    Get full text
    Journal Article
  3. 3

    Antimalarial Activity of Phenylthiazolyl-Bearing Hydroxamate-Based Histone Deacetylase Inhibitors by DOW, Geoffrey S, YUFENG CHEN, TRAN, Thanh N, KOZIKOWSKI, Alan P, ANDREWS, Katherine T, CARIDHA, Diana, GERENA, Lucia, GETTAYACAMIN, Montip, JOHNSON, Jacob, QIGUI LI, MELENDEZ, Victor, OBALDIA, Nicanor

    Published in Antimicrobial Agents and Chemotherapy (01-10-2008)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki by Dow, Geoffrey S, Magill, Alan J, Ohrt, Colin

    Published in Therapeutics and clinical risk management (01-08-2008)
    “…Malaria is of continuing concern in nonimmune traveling populations. Traditionally, antimalarial drugs have been developed as agents for dual indications…”
    Get full text
    Journal Article
  6. 6

    The Antimalarial Potential of 4-Quinolinecarbinolamines May Be Limited due to Neurotoxicity and Cross-Resistance in Mefloquine-Resistant Plasmodium falciparum Strains by DOW, Geoffrey S, KOENIG, Michael L, WOLF, Lesley, GERENA, Lucia, LOPEZ-SANCHEZ, Miriam, HUDSON, Thomas H, BHATTACHARJEE, Apurba K

    Published in Antimicrobial Agents and Chemotherapy (01-07-2004)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  7. 7

    A Series of Potent and Selective, Triazolylphenyl-Based Histone Deacetylases Inhibitors with Activity against Pancreatic Cancer Cells and Plasmodium falciparum by Chen, Yufeng, Lopez-Sanchez, Miriam, Savoy, Doris N, Billadeau, Daniel D, Dow, Geoffrey S, Kozikowski, Alan P

    Published in Journal of medicinal chemistry (26-06-2008)
    “…The discovery of the rules governing the inhibition of the various HDAC isoforms is likely to be key to identifying improved therapeutics that act as…”
    Get full text
    Journal Article
  8. 8

    Synthesis of an 8-pentafluorosulfanyl analog of the antimalarial agent mefloquine by Mo, Tingting, Mi, Xueling, Milner, Erin E., Dow, Geoffrey S., Wipf, Peter

    Published in Tetrahedron letters (29-09-2010)
    “…The 8-SF 5 analog of mefloquine was synthesized in nine steps from commercially available starting materials and in five steps from a novel ortho-SF…”
    Get full text
    Journal Article
  9. 9

    Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries by Dow, Geoffrey S, Liu, Jun, Lin, Gina, Hetzell, Brian, Thieling, Sarah, McCarthy, William F, Tang, Douglas, Smith, Bryan

    Published in Malaria journal (26-11-2015)
    “…Tafenoquine is a long half-life primaquine analog being developed for malaria prophylaxis. The US Army recently performed a unified analysis of efficacy in…”
    Get full text
    Journal Article
  10. 10

    Tafenoquine is not neurotoxic following supertherapeutic dosing in rats by Dow, Geoffrey S, Brown, Tracey, Reid, Mark, Smith, Bryan, Toovey, Stephen

    Published in Travel medicine and infectious disease (01-05-2017)
    “…Abstract Background Tafenoquine is a new drug for malaria prevention. The goal of the present work was to conduct a specific neurobehavioral study in rats with…”
    Get full text
    Journal Article
  11. 11

    A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area by Dow, Geoffrey S, McCarthy, William F, Reid, Mark, Smith, Bryan, Tang, Douglas, Shanks, G Dennis

    Published in Malaria journal (06-02-2014)
    “…In 2000/2001, the Australian Defense Forces (ADF), in collaboration with SmithKline Beecham and the United States Army, conducted a field trial to evaluate the…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Transcriptional profiling of mefloquine-induced disruption of calcium homeostasis in neurons in vitro by Dow, Geoffrey S., Caridha, Diana, Goldberg, Michelle, Wolf, Lesley, Koenig, Michael L., Yourick, Debra L., Wang, Zhining

    Published in Genomics (San Diego, Calif.) (01-11-2005)
    “…Mefloquine is associated with adverse neurological effects that are mediated via unknown mechanisms. Recent in vitro studies have shown that mefloquine…”
    Get full text
    Journal Article
  16. 16

    Effect of sample size and P-value filtering techniques on the detection of transcriptional changes induced in rat neuroblastoma (NG108) cells by mefloquine by Dow, Geoffrey S

    Published in Malaria journal (27-02-2003)
    “…There is no known biochemical basis for the adverse neurological events attributed to mefloquine. Identification of genes modulated by toxic agents using…”
    Get full text
    Journal Article
  17. 17

    The acute neurotoxicity of mefloquine may be mediated through a disruption of calcium homeostasis and ER function in vitro by Dow, Geoffrey S, Hudson, Thomas H, Vahey, Maryanne, Koenig, Michael L

    Published in Malaria journal (12-06-2003)
    “…There is no established biochemical basis for the neurotoxicity of mefloquine. We investigated the possibility that the acute in vitro neurotoxicity of…”
    Get full text
    Journal Article
  18. 18

    Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki by Geoffrey S Dow, Alan J Magill, Colin Ohrt

    Published in Therapeutics and clinical risk management (01-09-2008)
    “…Geoffrey S Dow, Alan J Magill, Colin OhrtDivision of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, MD, USAAbstract: Malaria…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Plasmodium berghei: In VivoEfficacy of Albendazole in Different Rodent Models by Dow, Geoffrey S., Reynoldson, James A., Andrew Thompson, R.C.

    Published in Experimental parasitology (01-02-1998)
    “…Dow, G. S., Reynoldson, J. A., and Thompson, R. C. A. 1998.Plasmodium berghei: In vivoefficacy of albendazole in different rodent models.Experimental…”
    Get full text
    Journal Article